| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | President And CEO
1 company
Oconnell Daniel Joseph is a Chief Executive Officer at Acumen Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $2.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | ABOS Acumen Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 26,472 | $1.77 | $46,953.87 | -1.4% | +43.6% | - | |
| Jan 7, 2026 | ABOS Acumen Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 47,506 | $1.98 | $94,176.16 | -2.4% | +32.2% | - | |
| Jan 21, 2025 | ABOS Acumen Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 12,619 | $1.59 | $20,102.07 | -1.9% | -35.0% | +11.0% | |
| Jan 3, 2025 | ABOS Acumen Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 47,778 | $1.84 | $87,873.30 | -9.5% | -48.0% | +6.3% | |
| Jan 19, 2024 | ABOS Acumen Pharmaceuticals, Inc. | President And CEO | Sell | 15,200 | $3.47 | $52,753.12 | -2.9% | -12.7% | -54.4% |